SMTL ID : 5i5k.1 (1 other biounit)

Structure of complement C5 in complex with eculizumab

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 4.20 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 3 residues within 4Å: Chain A: S.860, N.909, N.911 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schatz-Jakobsen, J.A. et al., Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway. J Immunol. (2016)

Release Date

2016-03-16

Peptides

Complement C5: A
Eculizumab heavy chain (variable domain): B
Eculizumab light chain (variable domain): C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
H

C
L

Complement C5

Eculizumab heavy chain (variable domain)

Eculizumab light chain (variable domain)

Related Entries With Identical Sequence